chr11-5884624-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005165.2(OR52E4):c.332G>A(p.Gly111Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,613,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005165.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52E4 | NM_001005165.2 | c.332G>A | p.Gly111Asp | missense_variant | 2/2 | ENST00000641726.1 | |
LOC112268071 | XR_002957231.2 | n.365-3195C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52E4 | ENST00000641726.1 | c.332G>A | p.Gly111Asp | missense_variant | 2/2 | NM_001005165.2 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-62+52777C>T | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250712Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135474
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461344Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 34AN XY: 726980
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | The c.332G>A (p.G111D) alteration is located in exon 1 (coding exon 1) of the OR52E4 gene. This alteration results from a G to A substitution at nucleotide position 332, causing the glycine (G) at amino acid position 111 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at